Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
514 studies found for:    Open Studies | "Platelet Aggregation Inhibitors"
Show Display Options
Rank Status Study
21 Recruiting A Study to Compare if the Uptake of Ticagrelor in the Body Differs When Different Tablets Are Administered
Condition: Sickle Cell Disease
Interventions: Drug: Ticagrelor granule;   Drug: Ticagrelor pediatric tablets;   Drug: Ticagrelor pediatric tablets suspended in water;   Drug: Ticagrelor immediate release (IR) tablets (Commercial tablet)
22 Recruiting Bedside Testing of CYP2C19 Gene for Treatment of Patients With PCI With Antiplatelet Therapy
Conditions: Coronary Artery Disease;   Myocardial Infarction;   Heart Disease;   Vascular Disease;   Angina Pectoris;   Cardiovascular Disease;   Ischemia;   Infarction;   Embolism;   Thrombosis;   Chest Pain
Interventions: Drug: clopidogrel;   Drug: Ticagrelor or prasugrel
23 Recruiting Comparison of Loading Strategies With Antiplatelet Drugs in Patients Undergoing Elective Coronary Intervention
Condition: Angina Pectoris
Interventions: Drug: Prasugrel;   Drug: Clopidogrel
24 Recruiting A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients
Conditions: Prostate Cancer;   Cardiovascular Disease
Interventions: Behavioral: Nutrition;   Behavioral: Exercise;   Behavioral: Smoking cessation;   Drug: Antiplatelet agent, such as Aspirin, or other low-dose antiplatelet agent;   Drug: Statin, such as Simvastatin, Atorvastatin, Rosuvastatin, Pravastatin);   Drug: ACE inhibitor
25 Recruiting Pharmacodynamic Study of Cilostazol in Healthy Volunteers
Condition: Healthy
Interventions: Drug: Cilostazol;   Drug: Acetylsalicylic acid;   Drug: Clopidogrel
26 Not yet recruiting Proton Pump Inhibitor Prevent Dual Antiplatelet Agents Induced Gastrointestinal Ulcer After Coronary Artery Bypass Graft
Conditions: Gastric Ulcer Induced by Antiplatelet Agent;   Ulcer of the Gastrointestinal Tract;   Proton Pump Inhibitor
Intervention: Drug: Pantoprazole
27 Recruiting Dental Extractions in Patients Under Dual Antiplatelet Therapy
Condition: Blood Coagulation Disorders
Interventions: Device: HemCon Dental Dressing;   Device: Oxidized Cellulose Gauze
28 Recruiting What is the Optimal antiplatElet and Anticoagulant Therapy in Patients With Oral Anticoagulation Undergoing revasculariSaTion 2.
Conditions: Atrial Fibrillations;   Heart Valve Prostheses;   Acute Coronary Syndromes;   Coronary Artery Diseases;   Stroke;   Bleeding;   Myocardial Infarction
Intervention: Drug: Combination of chronic oral anticoagulation and a P2Y12 inhibitor with or without aspirin.
29 Not yet recruiting Start or STop Anticoagulants Randomised Trial (SoSTART)
Conditions: Intracranial Hemorrhages;   Intracranial Hemorrhage, Hypertensive;   Subarachnoid Hemorrhage;   Subdural Hematoma;   Intraventricular Hemorrhage;   Atrial Fibrillation;   Atrial Flutter;   Small Vessel Cerebrovascular Disease;   Microhaemorrhage
Interventions: Drug: Apixaban;   Drug: Rivaroxaban;   Drug: Edoxaban;   Drug: Dabigatran;   Drug: Acenocoumarol;   Drug: Phenindione;   Drug: Warfarin
30 Not yet recruiting Vorapaxar and Lower Extremity Bypass Grafts
Condition: Peripheral Artery Disease
Interventions: Drug: Vorapaxar;   Drug: Placebos
31 Recruiting Effects of Fish Oil and Physical Activity on Fatigue in Colorectal Cancer Patients Receiving Regorafenib
Conditions: Malignant Neoplasms of Independent (Primary) Multiple Sites;   Metastatic Colorectal Cancer
Interventions: Drug: Regorafenib;   Dietary Supplement: Fish Oil;   Other: Resistance Training;   Other: Walking Program;   Other: Placebo;   Behavioral: Symptom Questionnaire;   Behavioral: Quality of Life Questionnaires;   Other: Walk Test;   Other: Chair/Stand Test;   Other: Stretching Exercises
32 Recruiting Effect of Vascepa on Improving Coronary Atherosclerosis in People With High Triglycerides Taking Statin Therapy
Condition: Hypertriglyceridemia
Interventions: Drug: Vascepa;   Drug: placebo
33 Recruiting Study to Assess Safety and Efficacy of Ifetroban for Treatment of Portal Hypertension in Cirrhotic Patients
Conditions: Portal Hypertension;   Liver Cirrhosis
Interventions: Drug: Ifetroban;   Drug: Placebo
34 Recruiting Brain Amyloid and Vascular Effects of Eicosapentaenoic Acid
Condition: Alzheimer's Disease
Interventions: Drug: icosapent ethyl (IPE);   Other: gel cap placebo
35 Recruiting Effect of W-3 Polyunsaturated Fatty Acids on Serum Albumin Concentration in Patients With Acute Heart Failure, Hypoalbuminemia, and High Inflammatory Activity
Condition: Heart Failure
Interventions: Drug: Polyunsaturated fatty acids omega-3;   Drug: Placebo
36 Recruiting Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension
Conditions: Scleroderma, Diffuse;   Scleroderma, Systemic;   Scleroderma, Limited;   Sclerosis, Progressive Systemic;   Skin Diseases;   Connective Tissue Diseases;   Pathologic Processes;   Autoimmune Diseases
Interventions: Drug: Oral Ifetroban;   Drug: Oral Placebo
37 Not yet recruiting Vorapaxar Study for Maturation of AV Fistulae for Hemodialysis Access
Condition: Fistula
Interventions: Drug: Vorapaxar sulfate;   Drug: Placebo
38 Recruiting Attenuation of D-dimer Using Vorapaxar to Target Inflammatory and Coagulation Endpoints
Condition: HIV
Interventions: Drug: vorapaxar;   Drug: Placebo
39 Recruiting Prasugrel for Prevention of Early Saphenous Vein Graft Thrombosis
Condition: Coronary Artery Bypass
Interventions: Drug: Prasugrel;   Drug: Placebo
40 Recruiting Prospective Study on the Treatment of Unsuspected Pulmonary Embolism in Cancer Patients
Condition: Unsuspected Pulmonary Embolism
Intervention: Drug: Heparin, fondaparinux, vitamin-K antagonists, aspirin

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.